Germany
· Delayed Price · Currency is EUR Kobayashi Pharmaceutical Statistics
Total Valuation
FRA:KOY has a market cap or net worth of EUR 2.40 billion. The enterprise value is 2.00 billion.
| Market Cap | 2.40B |
| Enterprise Value | 2.00B |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
| Current Share Class | 74.34M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.42% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 33.92M |
Valuation Ratios
The trailing PE ratio is 36.25.
| PE Ratio | 36.25 |
| Forward PE | n/a |
| PS Ratio | 2.40 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 30.17 |
| EV / Sales | 2.04 |
| EV / EBITDA | 10.74 |
| EV / EBIT | 14.85 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.33 |
| Quick Ratio | 2.52 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 793.36 |
Financial Efficiency
Return on equity (ROE) is 5.20% and return on invested capital (ROIC) is 6.71%.
| Return on Equity (ROE) | 5.20% |
| Return on Assets (ROA) | 5.41% |
| Return on Invested Capital (ROIC) | 6.71% |
| Return on Capital Employed (ROCE) | 10.47% |
| Revenue Per Employee | 276,398 |
| Profits Per Employee | 18,313 |
| Employee Count | 3,615 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.26% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.26% |
| 50-Day Moving Average | 33.17 |
| 200-Day Moving Average | 34.13 |
| Relative Strength Index (RSI) | 39.82 |
| Average Volume (20 Days) | 10 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:KOY had revenue of EUR 999.18 million and earned 66.20 million in profits. Earnings per share was 0.89.
| Revenue | 999.18M |
| Gross Profit | 514.88M |
| Operating Income | 137.25M |
| Pretax Income | 86.93M |
| Net Income | 66.20M |
| EBITDA | 189.84M |
| EBIT | 137.25M |
| Earnings Per Share (EPS) | 0.89 |
Balance Sheet
The company has 415.68 million in cash and 4.87 million in debt, giving a net cash position of 410.80 million.
| Cash & Cash Equivalents | 415.68M |
| Total Debt | 4.87M |
| Net Cash | 410.80M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.28B |
| Book Value Per Share | 17.21 |
| Working Capital | 572.41M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 51.53%, with operating and profit margins of 13.74% and 6.63%.
| Gross Margin | 51.53% |
| Operating Margin | 13.74% |
| Pretax Margin | 8.70% |
| Profit Margin | 6.63% |
| EBITDA Margin | 19.00% |
| EBIT Margin | 13.74% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.61, which amounts to a dividend yield of 1.90%.
| Dividend Per Share | 0.61 |
| Dividend Yield | 1.90% |
| Dividend Growth (YoY) | -4.92% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.42% |
| Shareholder Yield | 3.32% |
| Earnings Yield | 2.76% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 28, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Jun 28, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
FRA:KOY has an Altman Z-Score of 8.15.
| Altman Z-Score | 8.15 |
| Piotroski F-Score | n/a |